Literature DB >> 36254322

Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.

Daokun Sun1, Hartzell V Schaff1, Virend K Somers2, Rick A Nishimura2, Jeffrey B Geske2, Joseph A Dearani1, Steve R Ommen2.   

Abstract

Background: Sleep-disordered breathing (SDB) is a risk factor for heart failure symptoms in patients with hypertrophic cardiomyopathy (HCM). However, the relationship between preoperative SDB and postoperative functional status after septal myectomy (SM) is unknown. In this study, we investigated the association of preoperative SDB with late self-reported health status among patients undergoing SM for obstructive HCM.
Methods: Prior to SM, an overnight pulse oximetry test was used to measure oxygen desaturation index (ODI), which indicates the average number of desaturation episodes with at least 4% of drops in oxygen level from baseline per hour of sleep. Patients reported postoperative function through a questionnaire-based survey completed 3-5 years following SM.
Results: We analyzed 264 patients who underwent transaortic SM from November 2005 through April 2016. On predischarge transthoracic echocardiography post-procedure, no significant difference was present in the extent of mitral valve regurgitation (P = 0.524), left ventricular outflow tract gradient (P = 0.405), or septal thickness (P = 0.744) related to ODI. At 3 to 5 years after their operation, 236 patients (89%) reported good or excellent health. Approximately 18% (n = 48) and 8% (n = 22) of the cohort continued to experience exertional dyspnea and chest tightness, respectively, on walking 2 blocks or less. A greater ODI was not an independent predictor of worse health status or residual symptoms. Conclusions: Relief of left ventricular outflow tract obstruction in patients with obstructive HCM improves symptoms, with 89% of patients reporting good or excellent health. Preoperative SDB is not significantly associated with late functional status after septal myectomy.
© 2022 The Authors.

Entities:  

Year:  2022        PMID: 36254322      PMCID: PMC9568685          DOI: 10.1016/j.cjco.2022.06.010

Source DB:  PubMed          Journal:  CJC Open        ISSN: 2589-790X


  24 in total

1.  Hypertrophic obstructive cardiomyopathy and sleep-disordered breathing: an unfavorable combination.

Authors:  Partho P Sengupta; Dan Sorajja; Mackram F Eleid; Virend K Somers; Steve R Ommen; James M Parish; Bijoy Khandheria; A Jamil Tajik
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-18

2.  Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy?

Authors:  Anita Nguyen; Hartzell V Schaff; Rick A Nishimura; Joseph A Dearani; Jeffrey B Geske; Brian D Lahr; Steve R Ommen
Journal:  Eur J Cardiothorac Surg       Date:  2018-03-01       Impact factor: 4.191

3.  Prevalence and Characteristics of Central Compared to Obstructive Sleep Apnea: Analyses from the Sleep Heart Health Study Cohort.

Authors:  Lucas M Donovan; Vishesh K Kapur
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

4.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

5.  Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy.

Authors:  Sophie Wells; Ethan J Rowin; Griffin Boll; Hassan Rastegar; Wendy Wang; Martin S Maron; Barry J Maron
Journal:  Am J Med       Date:  2018-01-31       Impact factor: 4.965

6.  Late Health Status of Patients Undergoing Myectomy for Obstructive Hypertrophic Cardiomyopathy.

Authors:  Anita Nguyen; Hartzell V Schaff; Steve R Ommen; Bernard J Gersh; Joseph A Dearani; Jeffrey B Geske; Brian D Lahr; Rick A Nishimura
Journal:  Ann Thorac Surg       Date:  2020-10-27       Impact factor: 4.330

7.  High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.

Authors:  Mackram F Eleid; Tomas Konecny; Marek Orban; Partho P Sengupta; Virend K Somers; James M Parish; Farouk Mookadam; Peter A Brady; Barbara L Sullivan; Bijoy K Khandheria; Steve R Ommen; A Jamil Tajik
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

Review 8.  Adherence to continuous positive airway pressure therapy: the challenge to effective treatment.

Authors:  Terri E Weaver; Ronald R Grunstein
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

9.  Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure.

Authors:  Tom V Cloward; James M Walker; Robert J Farney; Jeffrey L Anderson
Journal:  Chest       Date:  2003-08       Impact factor: 9.410

10.  Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire.

Authors:  Razvan Capota; Sebastian Militaru; Alin Alexandru Ionescu; Monica Rosca; Cristian Baicus; Bogdan Alexandru Popescu; Ruxandra Jurcut
Journal:  Health Qual Life Outcomes       Date:  2020-10-30       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.